NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH
Status:
Completed
Trial end date:
2020-02-18
Target enrollment:
Participant gender:
Summary
To determine the feasibility of a controlled trial examining the efficacy and safety of
non-vitamin K antagonist oral anticoagulants (NOACs) compared with ASA for stroke prevention
in patients with a high-risk of atrial fibrillation and previous intracerebral hemorrhage.